Effects exerted by otilonium bromide administration on precipitated opioid withdrawal syndrome in rats

Toxicology

Volumn 122, Issue 1-2, 1997, Pages 23-37

  Pinelli, A ^a   Trivulzio, S ^a   Vignati, S ^a  

^a Chemother Med T   (Italy)

Author keywords

Antiwithdrawal activity; Calcium antagonist; Opioid withdrawal syndrome; Otilonium bromide; Rats

Indexed keywords

CALCIUM ANTAGONIST; MORPHINE; NALOXONE; NIMODIPINE; OTILONIUM BROMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEFECATION; DRUG MECHANISM; INTRAPERITONEAL DRUG ADMINISTRATION; JUMPING; MALE; MORPHINE ADDICTION; NONHUMAN; ORAL DRUG ADMINISTRATION; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; RECTUM TEMPERATURE; SALIVATION; URINARY EXCRETION; WET DOG SHAKES; WITHDRAWAL SYNDROME;

ANIMALS; BEHAVIOR, ANIMAL; BODY TEMPERATURE; CALCIUM; DOGS; GASTROINTESTINAL MOTILITY; MALE; MORPHINE; NALOXONE; PARASYMPATHOLYTICS; QUATERNARY AMMONIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECTUM; SALIVA; SUBSTANCE WITHDRAWAL SYNDROME; URINATION;

ANIMALIA; CANIS FAMILIARIS;

EID: 0030814670     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(97)00073-5     Document Type: Article

References (56)

1. Armitage, P., 1955. Tests for linear trends in proportions and frequencies. Biometrics 11, 375-386.
2. Armitage, P., 1991. Statistica medica X Edizione. Milano, Feltrinelli: pp. 296-339; 382-394; 402-412.
3. Baeyens, J.M., Esposito, E., Ossowska, G., Samanin, R., 1987. Effects of peripheral and central administration of calcium channel blockers in the naloxone-precipitated abstinence syndrome in morphine-dependent rats. Eur. J. Pharmacol. 137, 9-13.
4. Baldi, F., Longanesi, A., Blasi, A., Monello, S., Cestari, R., Missale, G., Corazziari, E., Badiali, G., Marzio, L., Di Felice, F., et al., 1992. Octylonium bromide in the treatment of the iritable bowel syndrome: a clinical-functional study. Hepato-Gastroenterology 39, 392-395.
5. Barrios, M., Baeyens, J.H., 1988. Differential effects of calcium channel blockers and stimulants on morphine withdrawal in vitro. Eur. J. Pharmacol. 152, 175-178.
6. Benzi, G., Arrigoni, E., Panceri, P., Villa, R.F., D'Angelo, L., Panzarasa, L., Autelli, M., Berte, F., 1974. Action of some antispasmodic on gastrointestinal muscle. Digestion 11, 72-89.
7. Bhargava, H.N., 1978. The effects of divalent ions on morphine analgesia and abstinence syndrome in morphine-tolerant and dependent mice. Psycopharmacology 57, 223-225.
8. Blasig, J., Gramsch, C., Laschka, E., Herz, A., 1976. The role of dopamine in withdrawal jumping in morphine dependent rats. Arzneim Forsch 26, 1104-1106.
9. Bongianni, F., Carla, V., Moroni, F., Pellegrini, F., Giampietro, D.E., 1986. Calcium channel inhibitors suppress the morphine withdrawal syndrome in rats. Br. J. Pharamcol. 88, 561-567.
10. Bowman, W.C., Rand, M.J., 1980. Textbook of Pharmacology II edition. Blackwell Scientific Publications, Oxford, pp. 16.1-16.16; 31.1-31.15; 42.74-42.79.
11. Buccatusco, J.J., 1983. Cardiovascular changes during morphine withdrawal in the rat: effects of clonidine. Pharmacol. Biochem. Behav. 18, 209-215.
12. Chahl, L.A., Thornton, C.A., 1987. Locomotor activity and contracture of isolated ileum precipitated by naloxone following treatment of guinea-pigs with a single dose of morphine. J. Pharm. Pharmacol. 39, 52-54.
13. Cowan, A., 1993. Effects of opioids on the spontaneous behaviour of animals. In: Herz, A., Akil, H., Simon, E.J., (Eds.), Opioids II. Springer-Verlag, Berlin, pp. 393-428.
14. Cox, B., Ary, M., Chesarek, W., Lomax, P., 1976. Morphine hyperthermia in the rat: an action on the central thermostats. Eur. J. Pharmacol. 36, 33-39.
15. Giachetti, A., 1991. Pharmacological studies on otilonium bromide. Ital. J. Gastroenterol. 23, 56-59.
16. ++ uptake. J. Pharmacol. Exp. Ther. 209, 132-136.
17. Guerrero-Munoz, F., Guerrero, M.L., Way, E.L., 1979b. Effect of morphine on calcium uptake by lysed synaptosomes. J. Pharmacol. Exp. Ther. 211, 370-374.
18. Gulati, A., Bhargava, N.H., 1989. Brain and spinal cord 5-HT2 receptors of morphine-tolerant dependent and abstinent rats. Eur. J. Pharmacol. 167, 185-192.
19. Gulati, A., Bhargava, N.H., 1990. Down regulation of hypothalamic 5-HT1A receptors in morphine abstinent rats. Eur. J. Pharmacol. 182, 253-259.
20. Harris, L.S., Dewey, W.L., Howes, J.F., Kennedy, J.S., Pars, H., 1969. Narcotic-antagonist analgesics: interactions with cholinergic systems. J. Pharmacol. Exp. Ther. 169, 17-22.
21. Harris, R.A., Yamamoto, H., Loh, H.H., Way, E.L., 1977. Discrete changes in brain calcium with morphine analgesia, tolerance-dependence and abstinence. Life Sci. 20, 501-506.
22. + depolarization and calcium antagonists. Gen. Pharmacol. 17, 695-703.
23. Iwamoto, E.T., Harris, R.A., Loh, H.H., Way, E.L., 1978. Antinociceptive respsonses after microinjection of morphine or lanthanium in discrete rat brain sites. J. Pharmacol. Exp. Ther. 206, 46-55.
24. Jaffe, J.H., Martin, W.R., 1990. Opioid analgesic and antagonist. In: Goodman Gilman, A., Rall T.W., Nies, A.S., Taylor, P. (Eds.), The Pharmacological Basis of Therapeutics. 8th ed. Pergamon Press, New York, pp. 485-521.
25. Kromer, W., 1988. Endogenous and exogenous opioids in the control of gastrointestinal motility and secretion. Pharmacol. Rev. 40, 121-162.
26. Kromer, W., 1993. Gastrointestinal effects of opioids. In: Herz, A., Akil, H., Simon, E.J., (Eds.), Opioids II. Springer-Verlag, Berlin, pp. 163-190.
27. Kruszewska, A., Langwinsky, R., 1983. The role of central serotoninergic neurotransmission in the morphine abstinence syndrome in rats. Drug Alcohol. Depend. 12, 273-278.
28. Lal, H., 1975. Narcotic dependence, narcotic action and dopamine receptors. Life Sci. 17, 483-495.
29. Lal, H., Colpaert, F.C., Laudron, P., 1975. Narcotic withdrawal like mouse jumping produced by amphetamine and L-dopa. Eur. J. Pharmacol. 30, 113-116.
30. Lefkowitz, R.J., Hoffman, B.B., Taylor, P., 1996. Neurotransmission. In: Hardman, J.G., Limbird, L.E., Molineff, P.B., Ruddon, R.W., Goodman Gilman, A. (Eds.), Goodman and Gilman's The Pharmacological Basis of Therapeutics, IX Ed. McGraw-Hill, New York, pp. 105-141.
31. Lin, M.T., 1982. An adrenergic link in the hypothalamic pathways which mediates morphine and beta-endorphin induced hyperthermia in the rat. Neuropharmacol. 21, 613-617.
32. Lison, I., 1961. Statistica applicata alla biologia sperimentale. Milano, Casa Editrice Ambrosiana, pp. 96-102; 135-165; 351-369.
33. Maggi, C.A., Manzini, S., Meli, A., 1983. Octylonium bromide: a smooth muscle relaxant which interferes with calcium ions mobilization. Arch. Int. Pharmacodyn. Ther. 264, 305-323.
34. Manzini, S., Maggi, C.A., Parlani, M., Subissi, A., Meli, A., 1988. Further studies on the pharmacodynamic properties and organ selectivity of oclylonium bromide. Drug Exp. Clin. Res. 14, 265-270.
35. Middlemiss, D.N., Spedding, N., 1985. A functional correlate for dihydropyridine binding site in rat brain. Nature 314, 94-96.
36. 3H]nitrendipine binding and γ-aminobutyric acid release in rat hippocampus following repeated morphine administration. J. Neurochem. 53, 1507-1511.
37. Pappas, G.D., Rose, S., 1976. Localization of calcium deposists in the frog neuromuscolar junction at rest and following stimulation. Brain Res. 103, 362-365.
38. Poynard, T., Naveau, S., Mory, B., Chaput, J.C., 1994. Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Alim. Pharm. Ther. 8, 499-510.
39. 3H]nitrendipine binding sites in the brain in morphine-tolerant mice. Eur. J. Pharmacol. 102, 371-372.
40. Ramkumar, V., El-Fakahany, E.E., 1988. Prolonged morphine treatment increases rat brain dihydropyridine binding sites, possible involvment in development of morphine dependence. Eur. J. Pharmacol. 146, 73-83.
41. Redmond, D.E. Jr, Krystal, J.H., 1984. Multiple mechanisms of withdrawal from opioid drugs. Ann. Rev. Neurosci. 7, 443-478.
42. Ross, D.H., Lynn, S.C., Cardenas, H.L., 1977. Ions, opiate, and cellular adaptation. In: Broom, K. (Ed.), Alcohol and Opiate Neurochemical and Behavioral Mechanisms. Academic Press, New York, pp. 265-277.
43. Ross, D.H., Cardenas, H.L., 1979. Nerve cell calcium as a messenger for opiate and endorphin actions. Adv. Biochem. Psychopharmacol. 20, 301-336.
44. 3H]nitrendipine binding following chronic tretment with morphine. Neurochem. Int. 7, 1033-1036.
45. SAS Institute Inc. Version 6.08 SAS Campus drive Cary, NC 27513.
46. Scarpignato, C., Coruzzi, G., Zappia, L., Bertaccini, G., 1980. Azione dell' ottilonio bromuro sul tratto gastro-enterico in vivo. Il Farmaco 35, 249-257.
47. Snyder, S.H., Manning, D.C., Steranka, L.R., 1989. Bradikinin and pain. In: Goldstein, A. (Ed.), Molecular and Cellular Aspects of Drug Addiction. Springer-Verlag, Berlin, pp. 92-110.
48. Taylor, J.R., Elsworth, J.D., Garcia, E.J., Grant, S.J., Roth, R.H., 1988. Clonidine infusions into the locus coeruleus attenuate behavioural and neurochemical changes associated with naloxoneprecipitated withdrawal. Psychopharmacology 96, 121-134.
49. Thomforde, G.M., Malagelada, J.R., Camilleri, M., Yaksh, T.L., 1990. Demonstration of intrathecal and systemic morphine and ST-91 effects on fed canine upper gut motility. Digest Dis. Sci. 35, 1249-1256.
50. Turski, W.A., Czuczwar, S.J., Turski, L., Sieklucka-Dziuba, M., Kleinrok, Z., 1984. Studies on the mechanism of wet dog shakes produced by carbachol in rats. Pharmacology 28, 112-120.
51. 2 adrenoceptor and mu opioid receptor densities during morphine dependence and spontaneous withdrawal in rats. NS Arch. Pharmacol. 336, 530-537.
52. Waught, J.L., Barret, R.W., 1987. Modulation of morphine analgesia by opioid peptides. In: Akil, H., Lewis, J.W. (Eds.), Neurotransmitters and Pain Control. Karger, Basel, pp. 178-193.
53. Way, E.L., 1993. Opioids tolerance and physical dependence and their relationship: calcium, disposition and opioid action. In: Herz, A., Akil, H., Simon, E.J., (Eds.), Opiods II. Springer-Verlag, Berlin, pp. 579-596.
54. Yamamoto, H., Harris, R.A., Loh, H.H., Way, E.L., 1978. Effects of acute and chronic morphine treatments on calcium localization and binding in brain. J. Pharmacol. Exp. Ther. 205, 255-264.
55. Yaksh, T.L., 1993. The spinal actions of opioids. In: Herz, A., Akil, H., Simon, E.J., (Eds.), Opiods II. Springer-Verlag, Berlin, pp. 53-90.
56. Zappia, L., Molina, E., Scarpignato, C., Coruzzi, G., Bertaccini, G., 1980. Azione spasmolitica dell'ottilonio bromuro sulla motilità gastrointestinale in vitro. Il Farmaco 35, 258-264.